Search alternatives:
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
larger decrease » marked decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
larger decrease » marked decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
Between-group differences in 95% Area, Y Sway Amplitude and LFS during postural training.
Published 2025Subjects: -
7
-
8
Consolidation of training-induced changes in unipedal stance: 95% Area, Y Sway Amplitude and LFS.
Published 2025Subjects: -
9
-
10
-
11
-
12
-
13
-
14
Data.
Published 2025“…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …”
-
15
Baseline characteristics of patients.
Published 2025“…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …”
-
16
-
17
Demographics of the study population.
Published 2024“…In the comparison among the ipsilateral, contralateral side of iPD with clinical laterality, and disease control group, the OBH of the disease control group was significantly larger than both the ipsilateral and contralateral sides (<i>P</i> < 0.05). …”
-
18
Table 3 -
Published 2024“…In the comparison among the ipsilateral, contralateral side of iPD with clinical laterality, and disease control group, the OBH of the disease control group was significantly larger than both the ipsilateral and contralateral sides (<i>P</i> < 0.05). …”
-
19
-
20
Data Sheet 1_Efficacy and safety of anlotinib combined with 125I seed implantation for iodine-refractory thyroid cancer.docx
Published 2025“…Serum Tg levels declined significantly from baseline in all groups. No major procedural complications occurred, and treatment-related adverse reactions were mostly mild (Grade 1–2) and comparable among groups.…”